Results 181 to 190 of about 79,614 (239)

Discovery of Cis-Regulatory Mechanisms via Non-Coding Mutations in Acute Lymphoblastic Leukemia. [PDF]

Genes Chromosomes Cancer
Aydın E, Woodward EL, Dushime GT, Gunnarsson R, Lilljebjörn H, Moura-Castro LH, Fioretos T, Johansson B, Paulsson K, Yang M.   +9 more
europepmc   +1 more source

In Vitro Purging of Acute Lymphoblastic Leukemia (B-ALL) Cells with the Use of PTL, DMAPT, or PU-H71. [PDF]

Int J Mol Sci
Ortiz-Reyes AE, García-Sánchez S, Serrano M, Núñez-Enriquez JC, Alvarado-Moreno JA, Montesinos JJ, Fajardo-Orduña G, Guzman ML, Villasis-Keever MA, Mancilla-Herrera I, Mayani H, Chavez-Gonzalez A.   +11 more
europepmc   +1 more source

Two Entities of Precursor T-Cell Lymphoblastic Leukemia/Lymphoma Based on Radiologic and Immunophenotypic Findings

International Journal of Hematology, 2004
Precursor T-cell lymphoblastic leukemia/lymphoma (T-ALL/LBL) presents a mediastinal mass in one half of cases. Although the immunophenotypic features of T-ALL/LBL have been analyzed in several studies, few studies have been focused on the relationship between the anatomic distribution of lesions and immunophenotypic findings.
Yasushi Onishi, Yoshihiro Matsuno, Ukihide Tateishi, Akiko Miyagi Maeshima, Masahiko Kusumoto, Takashi Terauchi, Shigeru Kusumoto, Naohiro Sekiguchi, Kazuki Tanimoto, Takashi Watanabe, Yukio Kobayashi, Kensei Tobinai   +11 more
semanticscholar   +5 more sources

Recent Developments in the Management of T-Cell Precursor Acute Lymphoblastic Leukemia/Lymphoma [PDF]

Current Hematologic Malignancy Reports, 2012
T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma are uncommon disorders classified together by the World Health Organization classification as "T-lymphoblastic leukemia/lymphoma." This review gives an overview on the treatment of these aggressive but curable T cell malignancies in adult patients, in order to highlight current ...
Adele K. Fielding, Lalita Banerjee, David I. Marks   +2 more
semanticscholar   +4 more sources

Human medicines European public assessment report (EPAR): Ivozall, clofarabine, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Date of authorisation: 14/11/2019, Status: Authorised

Case Medical Research, 2019

semanticscholar   +4 more sources

Some of the next articles are maybe not open access.

Related searches:

Outcomes of adult patients with early T-cell precursor (ETP) acute lymphoblastic leukemia/lymphoma (ALL) and non-ETP T-ALL

International Journal of Hematology, 2023
Early T-cell precursor (ETP) acute lymphoblastic leukemia/lymphoma (ALL) is generally considered to be a high-risk subtype. We retrospectively analyzed the clinical outcomes of adult patients diagnosed with ETP-ALL or other T-cell ALL (non-ETP T-ALL).
Yasushi Onishi, Eijiro Furukawa, Mayumi Kamata, Masahiko Fukatsu, Yoshihiro Kameoka, Shunsuke Hatta, Hiroyuki Hamada, Tatsuo Oyake, Tatsuyuki Kai, Masumi Sukegawa, Shinji Nakajima, Ryo Yanagiya, Kohei Yamaguchi, Taro Takahashi, Yoriko Harazaki, Toru Izumi, Kazunori Murai, Shigeki Ito, Takayuki Ikezoe, Kenichi Ishizawa, Naoto Takahashi, Hideo Harigae   +21 more
openaire   +3 more sources

Human medicines European public assessment report (EPAR): Sprycel, dasatinib, Precursor Cell Lymphoblastic Leukemia-Lymphoma,Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Date of authorisation: 20/11/2006, Revision: 32, Status: Authorised

Case Medical Research, 2019

semanticscholar   +4 more sources

Early T-cell Precursor Acute Lymphoblastic Leukemia/Lymphoma

Surgical Pathology Clinics, 2013
Discrete diagnostic subtypes of T lymphoblastic leukemia/lymphoma (T-cell acute lymphoblastic leukemia/lymphoma, T-ALL) have historically not been widely recognized. Recently, a novel subset with distinctive immunophenotypic, molecular, and clinical features has been proposed.
David R. Czuchlewski, Kathryn Foucar
openalex   +4 more sources

Human medicines European public assessment report (EPAR): Besponsa, inotuzumab ozogamicin, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Date of authorisation: 28/06/2017, Revision: 3, Status: Authorised

Case Medical Research, 2018

semanticscholar   +3 more sources

Precursor T-cell acute lymphoblastic leukemia/lymphoma involving the uterine cervix, myometrium, endometrium, and appendix

Annals of Diagnostic Pathology, 2002
This report presents a case of precursor T-cell acute lymphoblastic leukemia/lymphoma (ALL) involving the uterine cervix, myometrium, endometrium, and appendix. The patient was a 38-year-old woman with a history of ALL who had been in remission for 4 years following chemotherapy.
Mark D. Lyman, Thomas S. Neuhauser
openalex   +4 more sources